What Researchers Did
The researchers searched the medical literature on bleeding bladder inflammation in children after stem cell transplants and wrote evidence-based guidelines for prevention and treatment.
What They Found
This systematic review found that the evidence for the most commonly used treatments of haemorrhagic cystitis in children after stem cell transplant is very limited. Those treatments included cidofovir, oestrogen, hyperbaric oxygen, and bladder instillation with formalin, alum salts or prostaglandin. The review noted that some of these treatments also carry significant risks. Higher level evidence exists only for MESNA and hyperhydration as prevention, and for systemic recombinant Factor VII to stop acute bleeding. The abstract reports no figures such as patient numbers or outcome rates.
What This Means for Canadian Patients
For children with haemorrhagic cystitis after a stem cell transplant, the abstract lists hyperbaric oxygen among several commonly used treatments whose supporting evidence is very limited. It does not describe a hyperbaric protocol, pressure or number of sessions, and it does not say whether hyperbaric oxygen works. Families should talk with their transplant team about which options have the strongest evidence.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The review found that the evidence for most treatments, including hyperbaric oxygen, was very limited, so the guidance rests on weak data, and the authors state that high-quality studies are still required to establish effective and safe options.